Page last updated: 2024-10-24

candesartan and Anemia

candesartan has been researched along with Anemia in 1 studies

candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Meara, E1
Clayton, T1
McEntegart, MB1
McMurray, JJ1
Lang, CC1
Roger, SD1
Young, JB1
Solomon, SD1
Granger, CB1
Ostergren, J1
Olofsson, B1
Michelson, EL1
Pocock, S1
Yusuf, S1
Swedberg, K1
Pfeffer, MA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Anemia in Chronic Heart Failure: Etiology, Comparisons With Renal Disease, and Relationships With Biomarkers and Left Ventricular Remodeling.[NCT00834691]180 participants (Anticipated)Observational2008-01-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for candesartan and Anemia

ArticleYear
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program.
    Circulation, 2006, Feb-21, Volume: 113, Issue:7

    Topics: Aged; Anemia; Benzimidazoles; Biphenyl Compounds; Female; Glomerular Filtration Rate; Heart Failure;

2006